SEC Form 4 · accession 0001491519-18-000002
AMERICAN BIO MEDICA CORP · ABMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chaim Davis
Director
Period of report
Oct 5, 2018
Accepted (ET)
Oct 9, 2018 · 12:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896747
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF2 | Oct 5, 2018 | A | 35,036 | $0.09 | A | 93,543 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F135,036 shares of restricted stock were issued to Davis as compensation for his attendance at a meeting of the Board of Directors held in October 2008. This stock issuance is in accordance with the director compensation structure approved by the Company's Board of Directors on March 22, 2018 (as indicated in the Company's Proxy Statement filed on April 20, 2018.)
- F2The volume weighted average price of the Company's common shares for the 10 days preceding the issuance was $0.09 per share.